Aprea Therapeutics, Inc. (APRE)
0.7943
-0.01
(-1.49%)
USD |
NASDAQ |
Sep 04, 16:00
0.7902
0.00 (0.00%)
After-Hours: 20:00
Aprea Therapeutics SG&A Expense (TTM) : 6.507M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.507M |
| March 31, 2026 | 6.531M |
| December 31, 2025 | 6.477M |
| September 30, 2025 | 5.912M |
| June 30, 2025 | 6.037M |
| March 31, 2025 | 6.294M |
| December 31, 2024 | 6.459M |
| September 30, 2024 | 7.029M |
| June 30, 2024 | 7.144M |
| March 31, 2024 | 6.992M |
| December 31, 2023 | 8.428M |
| September 30, 2023 | 8.905M |
| June 30, 2023 | 10.27M |
| March 31, 2023 | 24.20M |
| December 31, 2022 | 24.82M |
| September 30, 2022 | 26.07M |
| June 30, 2022 | 26.40M |
| March 31, 2022 | 14.11M |
| Date | Value |
|---|---|
| December 31, 2021 | 13.55M |
| September 30, 2021 | 15.08M |
| June 30, 2021 | 15.14M |
| March 31, 2021 | 15.58M |
| December 31, 2020 | 14.93M |
| September 30, 2020 | 13.97M |
| June 30, 2020 | 12.81M |
| March 31, 2020 | 9.022M |
| December 31, 2019 | 6.246M |
| September 30, 2019 | 2.308M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Zymeworks, Inc. | 63.98M |
| Rhythm Pharmaceuticals, Inc. | 240.94M |
| Onconetix, Inc. | 8.131M |
| ACADIA Pharmaceuticals, Inc. | 620.29M |
| Alnylam Pharmaceuticals, Inc. | 1.318B |